Table 2 Blood transfusion, hemorrhage control requirements, and outcomes
| Variable |
Non-geriatric age group (n = 12,241) |
Geriatric age group (n = 1653) | p-value |
|---|---|---|---|
| Blood transfusion, units | |||
| Within 4 h | |||
| RBC, median (IQR) | 9 (6–14) | 8 (6–13) | < 0.001 |
| Plasma, median (IQR) | 6 (3–9) | 4 (3–9) | < 0.001 |
| Platelets, median (IQR) | 1 (0–2) | 1 (0–2) | 0.024 |
| Within 24 h | |||
| RBC, median (IQR) | 11 (7–16) | 10 (7–16) | 0.188 |
| Plasma, median (IQR) | 7 (4–12) | 6 (4–11) | 0.001 |
| Platelets, median (IQR) | 2 (1–3) | 2 (1–3) | 0.074 |
| Hemorrhage control | |||
| Angioembolization, n (%) | 1713 (13.9) | 337 (20.4) | < 0.001 |
| Surgery, n (%) | 9743 (79.6) | 1128 (68.2) | < 0.001 |
| Outcome | |||
| In-hospital mortality, n (%) | 3464 (28.3) | 782 (47.3) | < 0.001 |
| 24-h mortality, n (%) | 2231 (18.2) | 430 (26.0) | < 0.001 |
| Hospital LOS, median (IQR) | 14 (3–27) | 9 (1–22) | < 0.001 |
| ICU admission, n (%) | 10,641 (86.9) | 1444 (87.3) | 0.668 |
| ICU LOS, median (IQR) | 8 (2–12) | 7 (2–16) | 0.157 |
| Ventilator days, median (IQR) | 4 (2–12) | 4 (1–12) | 0.443 |
| Any adverse events, n (%) | 2685 (21.9) | 377 (22.8) | 0.440 |
| Cardiac failure, n (%) | 43 (0.4) | 44 (2.7) | < 0.001 |
| Respiratory failure, n (%) | 698 (5.7) | 82 (5.0) | 0.241 |
| Renal failure, n (%) | 856 (7.0) | 136 (8.2) | 0.075 |
| Thrombosis, n (%) | 1337 (11.0) | 134 (12.2) | 0.102 |
| Sepsis, n (%) | 370 (3.0) | 37 (3.0) | 1.000 |
| Others, n (%) | 1052 (8.6) | 149 (9.0) | 0.412 |